ifosfamide has been researched along with Cancer of Nose in 17 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Combination chemotherapy consisting of ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) was active as first-line and second-line treatment for extranodal natural killer/T-cell lymphoma (NTCL)." | 9.19 | A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group. ( Bae, SH; Chung, J; Heo, DS; Hyun, MS; Jeon, YK; Kang, YK; Kim, BS; Kim, CW; Kim, DW; Kim, H; Kim, HJ; Kim, TM; Lee, JS; Song, HS; Yang, SH; Yuh, YJ, 2014) |
| "Combination chemotherapy consisting of ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) was active as first-line and second-line treatment for extranodal natural killer/T-cell lymphoma (NTCL)." | 5.19 | A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group. ( Bae, SH; Chung, J; Heo, DS; Hyun, MS; Jeon, YK; Kang, YK; Kim, BS; Kim, CW; Kim, DW; Kim, H; Kim, HJ; Kim, TM; Lee, JS; Song, HS; Yang, SH; Yuh, YJ, 2014) |
| "Esthesioneuroblastoma (olfactory neuroblastoma) is a rare neuroendocrine tumor that arises in the upper nasal cavity from the olfactory epithelium." | 2.40 | Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. ( Buckner, JC; Lewis, JE; McElroy, EA, 1998) |
| "Therapy of esthesioneuroblastoma is challenging because of rarity and biologic variability of the tumor and and because of lack of a standard therapy." | 1.33 | [Long-term experiences in the therapy of esthesioneuroblastoma]. ( Constantinidis, J; Dimmler, A; Iro, H; Koch, M; Strauss, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Sánchez-Romero, C | 1 |
| Paes de Almeida, O | 1 |
| Díaz Molina, JP | 1 |
| Carlos, R | 1 |
| Wei, L | 1 |
| Wang, L | 1 |
| Cong, J | 1 |
| Yang, L | 1 |
| Ye, J | 1 |
| Li, X | 1 |
| Yao, N | 1 |
| Yang, J | 1 |
| Wang, J | 1 |
| Barthère, X | 1 |
| Guillerm, S | 1 |
| Quero, L | 1 |
| Le Maignan, C | 1 |
| Torossian, N | 1 |
| Verillaud, B | 1 |
| Itti, R | 1 |
| Hennequin, C | 1 |
| So, JC | 1 |
| Chan, KH | 1 |
| Pang, AW | 1 |
| Chan, JK | 1 |
| Kwong, YL | 1 |
| Kim, TM | 1 |
| Kim, DW | 2 |
| Kang, YK | 1 |
| Chung, J | 1 |
| Song, HS | 1 |
| Kim, HJ | 1 |
| Kim, BS | 2 |
| Lee, JS | 1 |
| Kim, H | 1 |
| Yang, SH | 1 |
| Yuh, YJ | 1 |
| Bae, SH | 1 |
| Hyun, MS | 1 |
| Jeon, YK | 1 |
| Kim, CW | 1 |
| Heo, DS | 2 |
| Oh, D | 1 |
| Ahn, YC | 2 |
| Kim, SJ | 2 |
| Kim, WS | 2 |
| Ko, YH | 2 |
| Celentano, A | 1 |
| Mascolo, M | 1 |
| Cirillo, N | 1 |
| De Rosa, G | 1 |
| Mignogna, MD | 1 |
| Yamaguchi, M | 3 |
| Tobinai, K | 1 |
| Oguchi, M | 1 |
| Ishizuka, N | 1 |
| Kobayashi, Y | 1 |
| Isobe, Y | 1 |
| Ishizawa, K | 1 |
| Maseki, N | 1 |
| Itoh, K | 1 |
| Usui, N | 1 |
| Wasada, I | 1 |
| Kinoshita, T | 1 |
| Ohshima, K | 1 |
| Matsuno, Y | 1 |
| Terauchi, T | 1 |
| Nawano, S | 1 |
| Ishikura, S | 1 |
| Kagami, Y | 1 |
| Hotta, T | 1 |
| Oshimi, K | 1 |
| Kim, K | 1 |
| Kim, CY | 1 |
| Suh, C | 1 |
| Huh, J | 1 |
| Lee, SW | 1 |
| Kim, JS | 1 |
| Cho, J | 1 |
| Lee, GW | 1 |
| Kang, KM | 1 |
| Eom, HS | 1 |
| Pyo, HR | 1 |
| Kobayashi, T | 1 |
| Hangaishi, A | 1 |
| Yamamoto, G | 1 |
| Shinohara, A | 1 |
| Morikawa, T | 1 |
| Takazawa, Y | 1 |
| Ota, S | 1 |
| Imai, Y | 1 |
| Nakamura, F | 1 |
| Kurokawa, M | 1 |
| Jo, YH | 1 |
| Kim, JH | 1 |
| Wu, HG | 1 |
| Rhee, CS | 1 |
| Lee, CH | 1 |
| Kim, TY | 1 |
| Bang, YJ | 1 |
| Kim, NK | 1 |
| Nitsche, M | 1 |
| Hermann, RM | 1 |
| Christiansen, H | 1 |
| Berger, J | 1 |
| Pradier, O | 1 |
| Koch, M | 1 |
| Constantinidis, J | 1 |
| Dimmler, A | 1 |
| Strauss, C | 1 |
| Iro, H | 1 |
| McElroy, EA | 1 |
| Buckner, JC | 1 |
| Lewis, JE | 1 |
| Cackett, P | 1 |
| Weir, C | 1 |
4 reviews available for ifosfamide and Cancer of Nose
| Article | Year |
|---|---|
Adult parameningial alveolar rhabdomyosarcoma: Case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Combined Modality Therapy; Dactin | 2020 |
[Concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Moda | 2010 |
Current and future management of NK/T-cell lymphoma based on clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Clinic | 2012 |
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; | 1998 |
3 trials available for ifosfamide and Cancer of Nose
| Article | Year |
|---|---|
A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Femal | 2014 |
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplati | 2009 |
Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dexa | 2009 |
10 other studies available for ifosfamide and Cancer of Nose
| Article | Year |
|---|---|
Pediatric nasal NK/T-cell lymphoma microscopically mimicking carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma; Chemorad | 2020 |
SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone | 2020 |
Diagnosis of brainstem involvement in NK/T cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Stem; Cerebrospinal Fluid; | 2014 |
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Chemoradiotherapy; Cisplati | 2015 |
Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chronic Disease; Delayed Diagno | 2017 |
Successful treatment of secondary NK/T-cell lymphoma of the testis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dexame | 2013 |
Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; | 2004 |
Rationale for individualized therapy in Sinonasal Teratocarcinosarcoma (SNTC): case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Combined Modality | 2005 |
[Long-term experiences in the therapy of esthesioneuroblastoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combin | 2006 |
Olfactory neuroblastoma--an unusual presentation.
Topics: Adult; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Diplopia; Esthesioneuroblastoma, Olfact | 2001 |